EXHIBIT 99.A
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information
required by Schedule 13D (or any amendment thereof) need be filed on their
behalf with respect to the beneficial ownership of any equity securities of
Criticare Systems, Inc. or any subsequent acquisitions or dispositions of equity
securities of Criticare Systems, Inc. by any of the undersigned.
Dated: March 9, 2001
(Signature Page Follows)
Signature Page 1 to Joint Filing Agreement
OXFORD BIOSCIENCE PARTNERS III LP
By: OBP Management III LP
By: /s/ Xxxxxxx X. Xxxxxx
General Partner
OXFORD BIOSCIENCE PARTNERS (ADJUNCT) III LP
By: OBP Management III LP
By: /s/ Xxxxxxx X. Xxxxxx
General Partner
OXFORD BIOSCIENCE PARTNERS (BERMUDA) III
LIMITED PARTNERSHIP
By: OBP Management III (Bermuda) Limited
Partnership
By: /s/ Xxxxxxx X. Xxxxxx
General Partner
mRNA FUND L.P.
By: mRNA PARTNERS L.P.
By: /s/ Xxxxxxx X. Xxxxxx
General Partner
OBP Management III LP
By: /s/ Xxxxxxx X. Xxxxxx
General Partner
OBP Management III (Bermuda) Limited Partnership
By: /s/ Xxxxxxx X. Xxxxxx
General Partner
-2-
Signature Page 2 to Joint Filing Agreement
mRNA PARTNERS L.P.
By: /s/ Xxxxxxx X. Xxxxxx
General Partner
/s/ Xxxxxxxx X. Xxxxxxx
Xxxxxxxx X. Xxxxxxx
/s/ Xxxxxxx X. Xxxxxx
Xxxxxxx X. Xxxxxx
/s/ Xxxx X. Xxxxxx
Xxxx X. Xxxxxx
/s/ Xxxxxxx X. Xxxxxxx
Xxxxxxx X. Xxxxxxx
-3-